GURUFOCUS.COM » STOCK LIST » Europe » Austria » WBO » Boston Scientific Corp (WBO:BSXC) » Definitions » Short Interest
Switch to:

Boston Scientific (WBO:BSXC) Short Interest

View and export this data going back to 2019. Start your Free Trial

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison

For the Medical Devices subindustry, Boston Scientific's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Boston Scientific Short Interest Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Boston Scientific's Short Interest distribution charts can be found below:

* The bar in red indicates where Boston Scientific's Short Interest falls in comparison to its industry or sector. The grey bar indicates the Short Interest's extreme value range as defined by GuruFocus.

Boston Scientific (WBO:BSXC) Business Description

Boston Scientific logo
300 Boston Scientific Way, Marlborough, MA, USA, 01752-1234
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

Boston Scientific (WBO:BSXC) Headlines

No Headlines